The 2015 WHO classification for pulmonary neuroendocrine tumors recommends only very rough Ki-67 limits (TC ≤ 5%, AC ≤ 20%, SCLC 50–100%, and LCNEC 40–80%) and calls for additional studies to generate more data [5]. This evidence concerns the gene MKI67 and small cell lung carcinoma.